(Q44188493)

30 November 2017

title

Formoterol provides long-lasting protection against exercise-induced bronchospasm (English)

1 reference

30 November 2017

1 reference

Edwin A Bronsky

1

1 reference

30 November 2017

Umit Yegen

2

1 reference

30 November 2017

Ching Ming Yeh

3

1 reference

30 November 2017

Lawrence V Larsen

4

1 reference

30 November 2017

Giovanni Della Cioppa

5

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Annals of Allergy, Asthma & Immunology

30 November 2017

published in

1 reference

30 November 2017

volume

89

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

407-412

1 reference

Exercise-induced bronchospasm in children: effects and therapies

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Chronic asthma: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Long-and short-acting beta 2-adrenergic agonists. Effects on airway function in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Rapid onset of action of inhaled formoterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Long-Acting Inhaled Beta Agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Dose-response of inhaled drugs in asthma. An update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962043-1

7 January 2021

10.1016/S1081-1206(10)62043-1

Identifiers

DOI

1 reference

30 November 2017

1 reference